| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Legal Officer | Director | EVP and General Counsel
2 companies
Parschauer Karah Herdman serves as an EVP and Chief Legal Officer at RARE and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 37 sells. Those positions are worth an estimated $2.3M at current prices.
Historically, Parschauer Karah Herdman's trades have earned a strong insider score of 77/100 across 15 rated trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +31.4%.
The biggest single holding is RARE (~$2.3M) as EVP and Chief Legal Officer. The recent filings there lean toward selling, a net 148,422 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 1,900 | $24.92 | $47,348.00 | -2.0% | - | - | |
| Jun 15, 2026 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 1,899 | $24.62 | $46,753.38 | -2.0% | -46.4% | - | |
| Mar 10, 2026 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 9,526 | $21.87 | $208,311.56 | -12.5% | -5.5% | - | |
| Mar 2, 2026 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 8,135 | $22.80 | $185,478.00 | -9.6% | -0.7% | - | |
| Sep 12, 2025 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 2,450 | $31.17 | $76,366.50 | -3.2% | +19.4% | -52.8% | |
| Mar 12, 2025 | EOLS Evolus, Inc. | Director | Sell | 12,888 | $12.99 | $167,465.38 | -28.6% | -26.5% | -63.4% | |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 12,846 | $42.10 | $540,816.60 | -14.6% | -12.4% | -46.5% | |
| Feb 27, 2025 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 2,990 | $42.88 | $128,223.90 | -5.2% | -18.2% | -44.3% | |
| Jun 12, 2024 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 9,806 | $45.00 | $441,270.00 | -14.5% | +24.8% | -12.0% | |
| Mar 1, 2024 | RARE Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | Sell | 3,756 | $53.76 | $201,922.56 | -5.3% | -28.0% | -20.1% |